Notice for dinutuximab beta (Emerge Health Pty Ltd)
Active ingredients
dinutuximab beta
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Intravenous Infusion
Indication
For the treatment of Neuroblastoma
Therapeutic area
Oncology